BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22740183)

  • 1. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.
    Dentali F; Sironi AP; Ageno W; Turato S; Bonfanti C; Frattini F; Crestani S; Franchini M
    Semin Thromb Hemost; 2012 Jul; 38(5):535-48. PubMed ID: 22740183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood group and vascular disease: an update.
    Dentali F; Sironi AP; Ageno W; Crestani S; Franchini M
    Semin Thromb Hemost; 2014 Feb; 40(1):49-59. PubMed ID: 24381150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients.
    Paiva SG; Sabino AP; Carvalho MG; Ribeiro DD; Gomes KB; Santos MS; Oliveira MS; Lages GG; Dusse LM; Fernandes AP
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):122-8. PubMed ID: 19786939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
    Moussaoui S; Saussoy P; Ambroise J; Defour JP; Zouitene R; Sifi K; Abadi N
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):105-115. PubMed ID: 26304686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Ohira T; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Zakai NA; Rosamond WD; Folsom AR
    J Thromb Haemost; 2007 Jul; 5(7):1455-61. PubMed ID: 17425663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
    Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO blood group and thrombotic vascular disease.
    Franchini M; Mannucci PM
    Thromb Haemost; 2014 Dec; 112(6):1103-9. PubMed ID: 25187297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
    Heit JA; Armasu SM; Asmann YW; Cunningham JM; Matsumoto ME; Petterson TM; De Andrade M
    J Thromb Haemost; 2012 Aug; 10(8):1521-31. PubMed ID: 22672568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Gohil R; Peck G; Sharma P
    Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.
    Trégouët DA; Heath S; Saut N; Biron-Andreani C; Schved JF; Pernod G; Galan P; Drouet L; Zelenika D; Juhan-Vague I; Alessi MC; Tiret L; Lathrop M; Emmerich J; Morange PE
    Blood; 2009 May; 113(21):5298-303. PubMed ID: 19278955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
    Kovac M; Kovac Z; Tomasevic Z; Vucicevic S; Djordjevic V; Pruner I; Radojkovic D
    Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis.
    Wu O; Bayoumi N; Vickers MA; Clark P
    J Thromb Haemost; 2008 Jan; 6(1):62-9. PubMed ID: 17973651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.